Tafamidis

2 trials NNeurology/Psychiatry Orphan designation

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

0 Recruiting

2 Completed trials

2 Sponsors

2 Countries

Phase IV

Phase I (Other)

Phase IV: 1 Phase I (Other): 1

Indications tested

Amyloidosis 1 Hereditary ATTR amyloid cardiomyopathy 1

Sponsors using this IMP

Pfizer Inc. 1 Unidade Local De Saude De Tras-Os-Montes E Alto Douro E.P.E. 1

All trials

2 total

MAGNETICAL - MAGNetic resonance Evaluation of Tafamidis Impact in Cardiac AmyLoidosis Ended

2024-518708-29-00 Phase IV 1 country Unidade Local De Saude De Tras-Os-Montes E Alto Douro E.P.E.
A study to learn how different forms of study medicine tafamidis are taken up into the blood in healthy adults Ended

2023-509241-12-00 Phase I (Other) 1 country Pfizer Inc.

Showing 1–2 of 2 trials

← All drugs A–Z